Compare KRMD & FT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KRMD | FT |
|---|---|---|
| Founded | 1980 | 1988 |
| Country | United States | United States |
| Employees | 73 | N/A |
| Industry | Medical/Dental Instruments | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 195.7M | 199.8M |
| IPO Year | 2019 | N/A |
| Metric | KRMD | FT |
|---|---|---|
| Price | $4.22 | $7.88 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $6.50 | N/A |
| AVG Volume (30 Days) | ★ 137.3K | 39.0K |
| Earning Date | 03-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.85% |
| EPS Growth | ★ 53.85 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $41,127,366.00 | N/A |
| Revenue This Year | $20.32 | N/A |
| Revenue Next Year | $17.38 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 22.23 | N/A |
| 52 Week Low | $1.87 | $6.71 |
| 52 Week High | $6.61 | $8.35 |
| Indicator | KRMD | FT |
|---|---|---|
| Relative Strength Index (RSI) | 36.30 | 31.72 |
| Support Level | $4.08 | $7.81 |
| Resistance Level | $4.34 | $7.86 |
| Average True Range (ATR) | 0.20 | 0.09 |
| MACD | 0.02 | -0.04 |
| Stochastic Oscillator | 23.36 | 1.37 |
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.
Franklin Universal Trust is a closed-end management investment company focused on providing high current income while preserving capital. Its secondary objective is to achieve income growth through dividend increases and capital appreciation. The fund invests in two asset classes: high-yield bonds and utility stocks. It applies fundamental research to build a diversified high-yield bond portfolio and targets utility companies with attractive dividend yields and a history of increasing dividends.